image

The best stocks to buy since 1993

Latest issue now available

Synergy Health - Receives 1950p bid; SCSW gain: 306%

November 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 1950p
Synergy has received a bid from STERIS (STE; US$61.8) worth £1.2 billion. The offer is 439p in cash + 0.4308 new STERIS shares, which values each share at 1950p. This represents a mouthwatering 27% premium to the previous all time high of 1530p in September.Based on N+1 Singer’s forecast, the offer   values the shares on 26.4x current year earnings and an EV/EBITDA of 12x but STERIS plans to extract $30m of cost synergies from the deal. STERIS has a market capitalisation of $3.3bn and the deal will leave Synergy holders with c.30% of the combined entity.We tipped the shares at 128p shortly after the company floated in July 01 and many times subsequently. Growth Portfolio 2 acquired a holding at 480p ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe